Search

An experimental cancer treatment cured this dog. Could it work for people?

AN EXPERIMENTAL CANCER TREATMENT CURED THIS DOG. COULD IT WORK FOR PEOPLE?

Our pets get sick in the same way we do. Finding cures for them is proving useful for us, too.

 
 
 
Eli Lilly Bolsters Cancer Drug Pipeline with $110M Deal for AurKa

ELI LILLY BOLSTERS CANCER DRUG PIPELINE WITH $110M DEAL FOR AURKA

Eli Lilly is pulling out its checkbook again to acquire another cancer drug developer, this time inking a deal for early-stage company...

PRECISION BIOSCIENCES TO PRESENT IN VIVO GENE THERAPY AND EX VIVO CANCER IMMUNOTHERAPY DATA AT THE AMERICAN SOCIETY OF GENE & CELL THERAPY ANNUAL MEETING

 
 
 
Agenda Posted for Xconomy's What's Hot in Boston Biotech on May 16

AGENDA POSTED FOR XCONOMY'S WHAT'S HOT IN BOSTON BIOTECH ON MAY 16

Join Xconomy next month for our sixth installment of What's Hot in Boston Biotech on May 16 at the Broad Institute of MIT and Harvard....

Merck Immunotherapy Drug Shines In Lung Cancer Study

MERCK IMMUNOTHERAPY DRUG SHINES IN LUNG CANCER STUDY

Research finds that more than two-thirds of lung cancer patients who received Keytruda plus chemotherapy would be alive a year later,...

 
 
 
New immunotherapy drug becomes first ever to DOUBLE survival in lung cancer patients

NEW IMMUNOTHERAPY DRUG BECOMES FIRST EVER TO DOUBLE SURVIVAL IN LUNG CANCER PATIENTS

Merck's Keytruda, given with standard chemotherapy, cut in half the risk of dying or having the cancer worsen, compared to chemo alone...

FOR MORE LUNG CANCER PATIENTS, THE PROMISE OF NO CHEMO LOOMS LARGER

[Editor's note: Ben Fidler co-authored this report.] A decade from now, it's possible that immunotherapy will have made a big dent...

 
 
 

ONCOSEC PROVIDES HIGHLIGHTS FROM RESEARCH RECEPTION AT AACR ANNUAL MEETING 2018

SAN DIEGO, April 16, 2018 /PRNewswire/ - OncoSec Medical Incorporated , a company developing intratumoral cancer immunotherapies, today...

 
 
 
Combination Therapy can Improve Outcomes in Bladder Cancer Patients

COMBINATION THERAPY CAN IMPROVE OUTCOMES IN BLADDER CANCER PATIENTS

Metastatic bladder cancer patients show better outcomes when treated simultaneously with chemotherapy and immunotherapy. Both the treatments...

DISPLAYING TETRA‐MEMBRANE SPANNING CLAUDINS ON ENVELOPED VIRUS‐LIKE PARTICLES FOR CANCER IMMUNOTHERAPY

Biotechnology Journal, Volume 13, Issue 3 , March 2018.

 
 
 
Combination Cancer Immunotherapy to Improve Response Rates

COMBINATION CANCER IMMUNOTHERAPY TO IMPROVE RESPONSE RATES

The combination of PD-1/L1 antibodies with anti-CD27 will lead to a better response rate in cancer patients.

Bio Roundup: Biotech IPOs, Migraine Progress, Takeda Woos Shire & More

BIO ROUNDUP: BIOTECH IPOS, MIGRAINE PROGRESS, TAKEDA WOOS SHIRE & MORE

If the recent IPO activity seems to be on overdrive, it's not your imagination. The number of companies filing to go public in the...

 
 
 
Arcus Bio Pulls Off IPO, Raises $120M for Cancer Immunotherapies

ARCUS BIO PULLS OFF IPO, RAISES $120M FOR CANCER IMMUNOTHERAPIES

Arcus Biosciences has raised $120 million from an initial public offering as the cancer immunotherapy developer looks ahead to reporting...

Unum, Homology Plan IPOs, as Unum Reveals Two Patient Deaths

UNUM, HOMOLOGY PLAN IPOS, AS UNUM REVEALS TWO PATIENT DEATHS

Two Boston-area biotech startups are shrugging off the recent stock market volatility as they press forward with plans for initial...

 
 
 
Paying for Gene Therapy, CRISPR in People, RNAi at “What's Hot” on May 16

PAYING FOR GENE THERAPY, CRISPR IN PEOPLE, RNAI AT “WHAT'S HOT” ON MAY 16

A new age of medicine is underway, and we're only just beginning to grapple with the implications. The first U.S. gene therapy , for...

 
 
 
Bio Roundup: Meldonium Slip, Kratom Crackdown, Zinc Fingers & More

BIO ROUNDUP: MELDONIUM SLIP, KRATOM CRACKDOWN, ZINC FINGERS & MORE

The 2018 Winter Olympics will end soon, and we did not skate through these games without a performance-enhancing drug allegation rearing...